Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Ocular Therapeutix, Inc. (OCUL)

Pharmaceutical Preparations

https://www.ocutx.com

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

24 CROSBY DRIVE
BEDFORD, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/25/2014

Market Cap

1,277,811,974

Shares Outstanding

110,220,000

Weighted SO

114,838,626

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

CTMX --.--%

ASMB --.--%

SPRO --.--%

ACHL --.--%

TERN --.--%

AMLX --.--%

ABOS --.--%

INZY --.--%

XFOR --.--%

Beta

1.2910

Last Div

0.0000

Range

1.995-11.31

Chg

-0.1748

Avg Vol

1903724

Mkt Cap

1277811974

Exch

NASDAQ

Country

US

Phone

781 357 4000

DCF Diff

9.3586

DCF

-0.0686

Div Yield

0.0000

P/S

20.9794

EV Multiple

-7.9339

P/FV

3.5981

Div Yield %

0.0000

P/E

-9.8219

PEG

0.4529

Payout

0.0000

Current Ratio

16.6350

Quick Ratio

16.5500

Cash Ratio

15.3373

DSO

181.1696

DIO

166.0691

Op Cycle

347.2388

DPO

240.5297

CCC

106.7091

Gross Margin

0.9081

Op Margin

-1.8794

Pretax Margin

-2.2716

Net Margin

-2.2716

Eff Tax Rate

0.0650

ROA

-0.2676

ROE

-0.6256

ROCE

-0.2350

NI/EBT

1.0000

EBT/EBIT

1.2087

EBIT/Rev

-1.8794

Debt Ratio

0.1330

D/E

0.1821

LT Debt/Cap

0.1509

Total Debt/Cap

0.1541

Int Coverage

17.5567

CF/Debt

-1.2167

Equity Multi

1.3691

Rec Turnover

2.0147

Pay Turnover

1.5175

Inv Turnover

2.1979

FA Turnover

3.6057

Asset Turnover

0.1178

OCF/Share

-0.5047

FCF/Share

-0.5150

Cash/Share

2.7721

OCF/Sales

-1.3741

FCF/OCF

1.0205

CF Coverage

-1.2167

ST Coverage

-50.5380

CapEx Coverage

-48.7994

Div&CapEx Cov

-48.7994

P/BV

3.5981

P/B

3.5981

P/S

20.9794

P/E

-9.8219

P/FCF

-14.9616

P/OCF

-16.2379

P/CF

-16.2379

PEG

0.4529

P/S

20.9794

EV Multiple

-7.9339

P/FV

3.5981

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 13, 22:09 Ocular Therapeutixâ„¢ Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. Dec 13, 22:09 Ocular Therapeutixâ„¢ Announces Pricing of Public Offering of Common Stock Benzinga Dec 13, 17:58 What Happened To Ocular Therapeutix Stock After-Hours? Benzinga Dec 13, 17:58 What Happened To Ocular Therapeutix Stock After-Hours? Benzinga Dec 13, 17:58 What Happened To Ocular Therapeutix Stock After-Hours? Benzinga Dec 13, 17:58 What Happened To Ocular Therapeutix Stock After-Hours? Benzinga Dec 13, 17:58 What Happened To Ocular Therapeutix Stock After-Hours?

Revenue Product Segmentation